List of Tables
Table 1. Global Autologous Cell Therapy Products Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Autologous Cell Therapy Products Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Autologous Cell Therapy Products Market Competitive Situation by Manufacturers in 2024
Table 4. Global Autologous Cell Therapy Products Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Autologous Cell Therapy Products Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Autologous Cell Therapy Products Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Autologous Cell Therapy Products Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Autologous Cell Therapy Products Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Autologous Cell Therapy Products, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Autologous Cell Therapy Products, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Autologous Cell Therapy Products, Product Type & Application
Table 12. Global Key Manufacturers of Autologous Cell Therapy Products, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Autologous Cell Therapy Products by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autologous Cell Therapy Products as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Autologous Cell Therapy Products Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Autologous Cell Therapy Products Sales by Region (2020-2025) & (K Units)
Table 18. Global Autologous Cell Therapy Products Sales Market Share by Region (2020-2025)
Table 19. Global Autologous Cell Therapy Products Sales by Region (2026-2031) & (K Units)
Table 20. Global Autologous Cell Therapy Products Sales Market Share by Region (2026-2031)
Table 21. Global Autologous Cell Therapy Products Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Autologous Cell Therapy Products Revenue Market Share by Region (2020-2025)
Table 23. Global Autologous Cell Therapy Products Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Autologous Cell Therapy Products Revenue Market Share by Region (2026-2031)
Table 25. North America Autologous Cell Therapy Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Autologous Cell Therapy Products Sales by Country (2020-2025) & (K Units)
Table 27. North America Autologous Cell Therapy Products Sales by Country (2026-2031) & (K Units)
Table 28. North America Autologous Cell Therapy Products Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Autologous Cell Therapy Products Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Autologous Cell Therapy Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Autologous Cell Therapy Products Sales by Country (2020-2025) & (K Units)
Table 32. Europe Autologous Cell Therapy Products Sales by Country (2026-2031) & (K Units)
Table 33. Europe Autologous Cell Therapy Products Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Autologous Cell Therapy Products Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Autologous Cell Therapy Products Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Autologous Cell Therapy Products Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Autologous Cell Therapy Products Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Autologous Cell Therapy Products Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Autologous Cell Therapy Products Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Autologous Cell Therapy Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Autologous Cell Therapy Products Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Autologous Cell Therapy Products Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Autologous Cell Therapy Products Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Autologous Cell Therapy Products Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Autologous Cell Therapy Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Autologous Cell Therapy Products Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Autologous Cell Therapy Products Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Autologous Cell Therapy Products Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Autologous Cell Therapy Products Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Autologous Cell Therapy Products Sales (K Units) by Type (2020-2025)
Table 51. Global Autologous Cell Therapy Products Sales (K Units) by Type (2026-2031)
Table 52. Global Autologous Cell Therapy Products Sales Market Share by Type (2020-2025)
Table 53. Global Autologous Cell Therapy Products Sales Market Share by Type (2026-2031)
Table 54. Global Autologous Cell Therapy Products Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Autologous Cell Therapy Products Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Autologous Cell Therapy Products Revenue Market Share by Type (2020-2025)
Table 57. Global Autologous Cell Therapy Products Revenue Market Share by Type (2026-2031)
Table 58. Global Autologous Cell Therapy Products Price (US$/Unit) by Type (2020-2025)
Table 59. Global Autologous Cell Therapy Products Price (US$/Unit) by Type (2026-2031)
Table 60. Global Autologous Cell Therapy Products Sales (K Units) by Application (2020-2025)
Table 61. Global Autologous Cell Therapy Products Sales (K Units) by Application (2026-2031)
Table 62. Global Autologous Cell Therapy Products Sales Market Share by Application (2020-2025)
Table 63. Global Autologous Cell Therapy Products Sales Market Share by Application (2026-2031)
Table 64. Global Autologous Cell Therapy Products Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Autologous Cell Therapy Products Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Autologous Cell Therapy Products Revenue Market Share by Application (2020-2025)
Table 67. Global Autologous Cell Therapy Products Revenue Market Share by Application (2026-2031)
Table 68. Global Autologous Cell Therapy Products Price (US$/Unit) by Application (2020-2025)
Table 69. Global Autologous Cell Therapy Products Price (US$/Unit) by Application (2026-2031)
Table 70. Novartis Company Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Novartis Autologous Cell Therapy Products Product
Table 74. Novartis Recent Developments/Updates
Table 75. Gilead Sciences Company Information
Table 76. Gilead Sciences Description and Business Overview
Table 77. Gilead Sciences Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Gilead Sciences Autologous Cell Therapy Products Product
Table 79. Gilead Sciences Recent Developments/Updates
Table 80. Bristol-Myers Squibb Company Information
Table 81. Bristol-Myers Squibb Description and Business Overview
Table 82. Bristol-Myers Squibb Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Bristol-Myers Squibb Autologous Cell Therapy Products Product
Table 84. Bristol-Myers Squibb Recent Developments/Updates
Table 85. Johnson & Johnson Company Information
Table 86. Johnson & Johnson Description and Business Overview
Table 87. Johnson & Johnson Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Johnson & Johnson Autologous Cell Therapy Products Product
Table 89. Johnson & Johnson Recent Developments/Updates
Table 90. Autolus Therapeutics Company Information
Table 91. Autolus Therapeutics Description and Business Overview
Table 92. Autolus Therapeutics Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Autolus Therapeutics Autologous Cell Therapy Products Product
Table 94. Autolus Therapeutics Recent Developments/Updates
Table 95. FOSUNKite Company Information
Table 96. FOSUNKite Description and Business Overview
Table 97. FOSUNKite Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. FOSUNKite Autologous Cell Therapy Products Product
Table 99. FOSUNKite Recent Developments/Updates
Table 100. JW Therapeutics Company Information
Table 101. JW Therapeutics Description and Business Overview
Table 102. JW Therapeutics Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. JW Therapeutics Autologous Cell Therapy Products Product
Table 104. JW Therapeutics Recent Developments/Updates
Table 105. CARsgen Therapeutics Company Information
Table 106. CARsgen Therapeutics Description and Business Overview
Table 107. CARsgen Therapeutics Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. CARsgen Therapeutics Autologous Cell Therapy Products Product
Table 109. CARsgen Therapeutics Recent Developments/Updates
Table 110. Sorrento Therapeutics Company Information
Table 111. Sorrento Therapeutics Description and Business Overview
Table 112. Sorrento Therapeutics Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Sorrento Therapeutics Autologous Cell Therapy Products Product
Table 114. Sorrento Therapeutics Recent Developments/Updates
Table 115. Mustang Bio Company Information
Table 116. Mustang Bio Description and Business Overview
Table 117. Mustang Bio Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Mustang Bio Autologous Cell Therapy Products Product
Table 119. Mustang Bio Recent Developments/Updates
Table 120. Cellectis Company Information
Table 121. Cellectis Description and Business Overview
Table 122. Cellectis Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Cellectis Autologous Cell Therapy Products Product
Table 124. Cellectis Recent Developments/Updates
Table 125. Allogene Therapeutics Company Information
Table 126. Allogene Therapeutics Description and Business Overview
Table 127. Allogene Therapeutics Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Allogene Therapeutics Autologous Cell Therapy Products Product
Table 129. Allogene Therapeutics Recent Developments/Updates
Table 130. Celyad Oncology Company Information
Table 131. Celyad Oncology Description and Business Overview
Table 132. Celyad Oncology Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Celyad Oncology Autologous Cell Therapy Products Product
Table 134. Celyad Oncology Recent Developments/Updates
Table 135. Bluebird Bio Company Information
Table 136. Bluebird Bio Description and Business Overview
Table 137. Bluebird Bio Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Bluebird Bio Autologous Cell Therapy Products Product
Table 139. Bluebird Bio Recent Developments/Updates
Table 140. Lonza Company Information
Table 141. Lonza Description and Business Overview
Table 142. Lonza Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Lonza Autologous Cell Therapy Products Product
Table 144. Lonza Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Autologous Cell Therapy Products Distributors List
Table 148. Autologous Cell Therapy Products Customers List
Table 149. Autologous Cell Therapy Products Market Trends
Table 150. Autologous Cell Therapy Products Market Drivers
Table 151. Autologous Cell Therapy Products Market Challenges
Table 152. Autologous Cell Therapy Products Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Autologous Cell Therapy Products
Figure 2. Global Autologous Cell Therapy Products Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Autologous Cell Therapy Products Market Share by Type: 2024 & 2031
Figure 4. Autologous Stem Cell Transplants Product Picture
Figure 5. Autologous T Cell Therapies Product Picture
Figure 6. Platelet-Rich Plasma (PRP) Therapy Product Picture
Figure 7. Others Product Picture
Figure 8. Global Autologous Cell Therapy Products Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Autologous Cell Therapy Products Market Share by Application: 2024 & 2031
Figure 10. Cancer
Figure 11. Hemophilia
Figure 12. Others
Figure 13. Global Autologous Cell Therapy Products Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Autologous Cell Therapy Products Market Size (2020-2031) & (US$ Million)
Figure 15. Global Autologous Cell Therapy Products Sales (2020-2031) & (K Units)
Figure 16. Global Autologous Cell Therapy Products Average Price (US$/Unit) & (2020-2031)
Figure 17. Autologous Cell Therapy Products Report Years Considered
Figure 18. Autologous Cell Therapy Products Sales Share by Manufacturers in 2024
Figure 19. Global Autologous Cell Therapy Products Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Autologous Cell Therapy Products Players: Market Share by Revenue in Autologous Cell Therapy Products in 2024
Figure 21. Autologous Cell Therapy Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Autologous Cell Therapy Products Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Autologous Cell Therapy Products Sales Market Share by Country (2020-2031)
Figure 24. North America Autologous Cell Therapy Products Revenue Market Share by Country (2020-2031)
Figure 25. United States Autologous Cell Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Autologous Cell Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Autologous Cell Therapy Products Sales Market Share by Country (2020-2031)
Figure 28. Europe Autologous Cell Therapy Products Revenue Market Share by Country (2020-2031)
Figure 29. Germany Autologous Cell Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Autologous Cell Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Autologous Cell Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Autologous Cell Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Autologous Cell Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Autologous Cell Therapy Products Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Autologous Cell Therapy Products Revenue Market Share by Region (2020-2031)
Figure 36. China Autologous Cell Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Autologous Cell Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Autologous Cell Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Autologous Cell Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Autologous Cell Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Autologous Cell Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Autologous Cell Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Autologous Cell Therapy Products Sales Market Share by Country (2020-2031)
Figure 44. Latin America Autologous Cell Therapy Products Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Autologous Cell Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Autologous Cell Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Autologous Cell Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Autologous Cell Therapy Products Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Autologous Cell Therapy Products Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Autologous Cell Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Autologous Cell Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Autologous Cell Therapy Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Autologous Cell Therapy Products by Type (2020-2031)
Figure 54. Global Revenue Market Share of Autologous Cell Therapy Products by Type (2020-2031)
Figure 55. Global Autologous Cell Therapy Products Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Autologous Cell Therapy Products by Application (2020-2031)
Figure 57. Global Revenue Market Share of Autologous Cell Therapy Products by Application (2020-2031)
Figure 58. Global Autologous Cell Therapy Products Price (US$/Unit) by Application (2020-2031)
Figure 59. Autologous Cell Therapy Products Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
